This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barry, A L Articles by McLaughlin, J C Search for Related Content PubMed PubMed Citation Articles by Barry, A L Articles by McLaughlin, J C

 Previous Article  |  Next Article 

J Clin Microbiol. 1993 March; 31(3): 751-753

Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.

Clinical Microbiology Institute, Tualatin, Oregon 97062.

ABSTRACT

In vitro studies evaluated methods for testing the susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations. Ampicillin-resistant beta-lactamase-nonproducing strains of H. influenzae may be presumed to be relatively resistant to combinations of piperacillin-tazobactam, even though they frequently appear to be susceptible by disk diffusion methods. Other ampicillin-resistant or -susceptible strains were predictably susceptible; i.e., 130 such strains gave zones of inhibition > or = 26 mm in diameter, and MICs for these strains were < or = 0.125/4.0 micrograms/ml (< or = 1.0/0.12 micrograms/ml when an 8:1 ratio was tested). A resistant category has yet to be defined. For quality control purposes, H. influenzae ATCC 49247 should give zones of inhibition 32 to 38 mm in diameter, and broth microdilution MICs should be 0.12/4.0 to 0.5/4.0 micrograms/ml.

This article has been cited by other articles:

• Gazagne, L., Delmas, C., Bingen, E., Dabernat, H. (1998). Molecular Epidemiology of Ampicillin-Resistant Non-beta -Lactamase-Producing Haemophilus influenzae. J. Clin. Microbiol. 36: 3629-3635 [Abstract] [Full Text]